We analysed representative proteins of the insulin/Akt/mTOR and insulin/Akt/FOXO3a pathways in the ALS mouse model, with and without training, and at different ALS stages to test this hypothesis. The gene discussed is FOXO3; the disease is amyotrophic lateral sclerosis.